These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 18388031

  • 61. Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain.
    Yentes JM, Huisinga JM, Myers SA, Pipinos II, Johanning JM, Stergiou N.
    J Appl Biomech; 2012 May; 28(2):184-91. PubMed ID: 22723116
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazol.
    Donnelly R.
    Diabetes Obes Metab; 2002 Mar; 4 Suppl 2():S20-5. PubMed ID: 12180354
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. The role of cilostazol (Pletal) in the management of intermittent claudication.
    Bradbury AW.
    Int J Clin Pract; 2003 Jun; 57(5):405-9. PubMed ID: 12846346
    [Abstract] [Full Text] [Related]

  • 67. [Randomized study of tolerability, safety and efficacy of Pletax in intermittent claudication].
    Kazantsev AN, Goriunov SV, Ershova OB, Erofeeva SB, Gurgenian EV.
    Angiol Sosud Khir; 2021 Jun; 27(1):7-16. PubMed ID: 33825723
    [Abstract] [Full Text] [Related]

  • 68. [Effectiveness of pentoxifylline and of bio-electromagnetic therapy in lower limb obliterative arterial disease].
    Bernát SI.
    Orv Hetil; 2013 Oct 20; 154(42):1674-9. PubMed ID: 24121220
    [Abstract] [Full Text] [Related]

  • 69. Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.
    Perhoniemi V, Salmenkivi K, Sundberg S, Johnsson R, Gordin A.
    Angiology; 1984 Jun 20; 35(6):366-72. PubMed ID: 6375469
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Management of patients with intermittent claudication.
    Olin JW.
    Int J Clin Pract; 2002 Nov 20; 56(9):687-93. PubMed ID: 12469984
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Effects of indobufen and pentoxifylline on walking capacity and hemostasis in patients with intermittent claudication: results of six months of treatment.
    Panchenko E, Eshkeeva A, Dobrovolsky A, Titaeva E, Podinovskaya Ya, Hussain KM, Karpov Yu.
    Angiology; 1997 Mar 20; 48(3):247-54. PubMed ID: 9071201
    [Abstract] [Full Text] [Related]

  • 78. Effects of pentoxifylline on severe intermittent claudication.
    Reich T, Gillings D.
    Angiology; 1987 Sep 20; 38(9):651-6. PubMed ID: 3310744
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.